ANTITRUST—S.D.N.Y.: Prior antitrust settlement does not bar Richmond’s FCA suit over federally taxable swaps - VitalLaw.com
ANTITRUST—S.D.N.Y.: Prior antitrust settlement does not bar Richmond’s FCA suit over federally taxable swapsVitalLaw.
A health care organization that discovers a billing error or questionable financial arrangement faces a hard choice: report it and invite scrutiny, or wait and risk worse consequences. On October 22, 2026, the U.S. Department of Justice (DOJ) and the U.S. Department of Health and Human Services (HHS) launched an alternative: the Healthcare False Claims Act Self-Disclosure Pilot Program (the “Pilot”). The HHS Office of Inspector General (OIG) and the Centers for Medicare & Medicaid Services (CMS) also participate. Organizations that come forward first with potential civil False Claims Act (FCA) violations can receive reduced repayment, a release with no factual admissions, and no Corporate Integrity Agreement (CIA).1
The window is short: disclosures are due by 11:59 p.m. on April 22, 2027. DOJ will not review partial submissions, and the Pilot is available only for conduct the government does not already know about.2
A Broader Federal Push for Voluntary Disclosure
The Pilot is part of a broader federal effort to encourage voluntary disclosure while increasing health care fraud enforcement, including an October 2026 DOJ enforcement directive3 and a coordinated criminal self-disclosure policy with HHS-OIG.4
The Pilot adds a defined resolution process for civil FCA violations, offering legitimate businesses a way to “move forward with a clean slate,” while DOJ warns that, for companies unwilling to take accountability, the Civil Division, “in partnership with...
ANTITRUST—S.D.N.Y.: Prior antitrust settlement does not bar Richmond’s FCA suit over federally taxable swapsVitalLaw.